← Back to The Daily Signal
Supplements & Nootropics

FDA Just Spelled Out What Proof a Brand New Supplement Ingredient Needs

Every few months a new supplement ingredient shows up with a clever name and a lot of confidence. What, if anything, did a company have to show before it got there? In October, FDA put more of that answer in writing.

Written by Sama Alabed · October 21, 2026

The short version

What FDA finalized

FDA's update, posted October 19, 2026, says it finalized three sections of its long pending guidance on new dietary ingredient notifications. A new dietary ingredient, or NDI, is one that was not sold in the United States before 1994. The sections cover identity (what exactly the ingredient is), the history of use or other safety evidence, and a summary of the basis for believing it is safe. The Federal Register notice followed on October 20. FDA says it will keep finalizing the remaining parts of the guidance in discrete sections.

FDA does not approve supplements the way it approves drugs, so this kind of filing matters. It is one of the few places where a company has to put identity and safety evidence in front of the agency before an ingredient it has not sold before goes on sale.

What the proof is supposed to look like

The details below are in the guidance itself, and Nutritional Outlook's summary reports them the same way.

A pressed and dried plant mounted on a herbarium sheet with a specimen label in the corner

Museums keep sheets like this one, a catnip specimen from Luxembourg, so researchers can check which species a plant really is.

Musée national d'histoire naturelle LuxembourgCC BY 4.0

Illustrative. A catnip herbarium sheet, not an ingredient named in the FDA guidance.

For a botanical, the company should verify the plant's taxonomy, meaning which species it really is, and describe how it was processed. For an extract, it should spell out the solvent, the extraction ratio and how the extract is standardized, so one batch can be compared with the next. And if a company leans on history of use alone to argue safety, the guidance says FDA generally recommends at least 25 years of widespread use, not a few years of popularity.

Those three points double as a plain language checklist for any trendy new ingredient: is it clear what it is, is it made the same way each time, and is there real safety evidence behind it.

is it clear what it is, is it made the same way each time, and is there real safety evidence behind it

What is still unsettled

Industry groups including AHPA and CRN say some concerns remain, such as when an ingredient counts as new in the first place. This is guidance, not a rule. It signals how FDA is likely to judge filings, and it does not bind anyone.

Honest caveat

This is nonbinding guidance, and it applies to company filings, not to products on the shelf today. The 25 year history of use figure is FDA's recommendation in the guidance, not a legal requirement. FDA's update is dated October 19 and the Federal Register notice October 20. Nothing here is a claim about the safety of any specific product.

What this means for you

You do not need to do anything differently today. What you can do is borrow the questions. When a new ingredient gets hyped, look for what species or compound it actually is, whether the extract is standardized, and what safety evidence exists beyond a long sales history. If a brand cannot answer those, that tells you something.

It also means a clearer bar is forming for novel ingredients, which is useful context the next time one lands in your feed.

Primary sources

  1. FDA constituent update, October 19, 2026, on the identity and safety information guidance for NDI notifications
  2. FDA guidance document, docket FDA-2025-D-6501
  3. Federal Register notice 2026-21453, October 20, 2026
  4. Nutritional Outlook, October 20, 2026, trade press summary and industry reaction

Common questions

Does FDA approve supplements before they are sold?

No. FDA does not pre approve dietary supplements. The new dietary ingredient notification is one of the few checks that happens before an ingredient they have not sold before reaches the market, and this guidance explains what that filing should contain.

Does this guidance apply to the supplement I take today?

Not directly. It describes what companies should submit for ingredients that were not marketed before 1994. It is nonbinding, and it says nothing about the safety of any specific product already on a shelf.

What does history of use mean in this guidance?

The guidance says FDA generally recommends 25 years of widespread use as the minimum to establish a history of safe use. That is a recommendation in nonbinding guidance, not a legal requirement.

Continue readingSupplements & NootropicsMore Than Half of Ginkgo in Published Studies Was Not Really GinkgoA peer reviewed review of 78 studies and nearly 3,000 samples found ginkgo adulterated or mislabeled in 57 percent of published samples, black cohosh in 42 percent, echinacea in 29 percent, ginseng in 25 percent, turmeric in 22 percent, and elderberry in 17 percent. Essential oils tested worse, with roughly 65 percent of bergamot, 52 percent of lavender, and 42 percent of peppermint oil samples adulterated, in cases linked to seizures and rancid oil sold as fresh. These are rates found in published testing, not a claim about what is on a store shelf today. A Bangladesh program that measured lead contaminated turmeric and then enforced against it took contaminated market samples from 47 percent to zero in four years, proof the problem is solvable.Read the story
SupplementsFDANew Dietary IngredientsBotanicalsRegulation

#Supplements#FDA#NewDietaryIngredient#Botanicals#SupplementRegulation

Stay Curious.

Better health isn't found in a single article. It's built through curiosity, evidence, and small discoveries over time. Join thousands exploring longevity, gut health, recovery, nutrition, and the tools that truly make a difference.